Latest Financials News

Elixir Energy has advanced its strategic plan in Queensland’s Taroom Trough, appointing a new COO, initiating a major cost reduction, and preparing to drill key exploration and appraisal wells that could unlock significant gas resources.

Helios Energy is making tangible progress restarting production at its Presidio Oil Project in Texas, while strategically enhancing its US-based technical leadership to support future growth.

Norwood Systems delivered its strongest quarter yet with record cash inflows, significant debt reduction, and expanding global partnerships, setting a robust foundation for FY2026.

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.

Barton Gold Holdings has revealed a preliminary A$26 million refurbishment plan for its Central Gawler Mill, aiming to restart production by the end of 2026 with significant cost and operational advantages.

Copper Search Limited made significant strides in the June 2025 quarter, revealing promising Heavy Mineral Sands potential in South Australia and securing a strategic option over a major NSW gold-copper project, while raising $1.15 million to fuel its exploration ambitions.

Meteoric Resources’ Pre-Feasibility Study confirms the Caldeira Project in Brazil as a globally significant rare earths deposit, boasting robust economics, low operating costs, and strong sustainability credentials. The study underpins a 20-year mine life with substantial growth potential amid rising global demand for critical minerals.

Noble Helium appoints Dennis Donald as Executive Chairman and secures a $200k loan to accelerate its North Rukwa helium project, backed by positive technical reviews.

Aura Energy has marked significant progress toward uranium production at its Tiris project in Mauritania, while forging a key collaboration to advance uranium exploration in Sweden amid shifting regulatory landscapes.

PYC Therapeutics reports solid progress across its four RNA therapeutic programs targeting genetic diseases, backed by a strong cash position extending runway beyond 2027.

Insignia Financial has provided an update on its ongoing discussions with CC Capital Partners regarding a potential acquisition via a scheme of arrangement. While talks continue, there is no certainty a deal will be reached.

AMP Limited reports a strong second quarter with Platforms net cashflows soaring 63.2% and Superannuation & Investments achieving positive net cashflows for the first time since 2017. AMP Bank remains steady amid ongoing innovation and market volatility.